Would increasing Remeron (mirtazapine) from 7.5 mg to 15 mg help with fatigue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Increasing Mirtazapine from 7.5 mg to 15 mg Will Likely Worsen Fatigue, Not Improve It

No, increasing mirtazapine from 7.5 mg to 15 mg will likely worsen your fatigue rather than help it. This counterintuitive dosing paradox occurs because mirtazapine's sedating antihistamine (H1) effects are most pronounced at lower doses, while higher doses engage more noradrenergic activity that can offset sedation 1, 2.

The Dose-Dependent Sedation Paradox

Mirtazapine exhibits an inverted U-curve for sedation:

  • At 7.5 mg: Maximum H1 antihistamine blockade causes pronounced sedation and daytime sleepiness
  • At 15-45 mg: Increased noradrenergic activity partially counteracts H1 effects, reducing (though not eliminating) sedation 2

The FDA-approved starting dose is 15 mg, not 7.5 mg, specifically because the lower dose produces more sedation 1. Research confirms that 7.5 mg causes no driving impairment but significant subjective somnolence, while 15 mg impairs driving performance—suggesting different mechanisms of sedation at each dose 3.

Evidence for Fatigue Improvement at Higher Doses

A 2011 study demonstrated that mirtazapine treatment (at therapeutic doses, not sub-therapeutic) significantly improved both daytime sleepiness and fatigue in depressed patients, with improvements measured on multiple validated scales (MSLT, ESS, SSS, FIS, FAF) 4. However, this benefit occurred when treating depression at proper therapeutic doses (15-45 mg), not at the sub-therapeutic 7.5 mg dose.

Most recent evidence (2025) specifically identifies bupropion—not mirtazapine—as superior for treating hypersomnia, increased appetite, and fatigue in depression 5. Conversely, mirtazapine excels at treating insomnia and decreased appetite 5.

Clinical Algorithm for Your Situation

If your primary complaint is fatigue:

  1. Discontinue mirtazapine entirely rather than increasing it—even at 15 mg, fatigue remains a common adverse effect 6
  2. Switch to bupropion, which has the strongest evidence for improving fatigue, hypersomnia, and increased appetite in depression 5
  3. If switching isn't feasible, increase to the FDA-recommended 15 mg minimum and wait 1-2 weeks to assess 1—but expect only partial improvement in fatigue

If your primary complaint is insomnia or poor sleep:

  1. Increasing to 15 mg is appropriate and will help 5
  2. The therapeutic range is 15-45 mg daily 1

Critical Caveats

  • 7.5 mg is sub-therapeutic for depression—the FDA label explicitly states 15 mg is the starting dose 1
  • Dose changes require 1-2 weeks for evaluation 1
  • About 63% of patients on second-generation antidepressants experience fatigue as an adverse effect 6
  • Women and elderly patients have 18-27% higher mirtazapine blood levels at the same dose, increasing sedation risk 7

The evidence strongly suggests that if fatigue is your concern, you need a different medication strategy entirely, not a dose increase of mirtazapine.

Related Questions

Why does mirtazapine cause less sedation at higher doses?
Is it safe to take 7.5 mg of mirtazapine at 7 p.m. after dinner and another 15 mg at bedtime?
Is mirtazapine an antidepressant and anxiolytic?
What advice should be given to a patient taking mirtazapine 7.5 mg who is experiencing drowsiness?
Does mirtazapine have anticholinergic activity?
What are odd beliefs in schizotypal personality disorder and how are they managed?
What are the differential diagnoses for a 77‑year‑old woman with hypoalbuminemia, low total protein, hypogammaglobulinemia (gamma‑globulin 0.3 g/dL), low serum free kappa light chain (75 mg/L), low serum free lambda light chain (43 mg/L), and low immunoglobulins IgG (309 mg/dL), IgM (34 mg/dL) and IgA (62 mg/dL)?
What is the approximate amount of nicotine delivered from one cigarette?
What are the differential diagnoses for a female patient who is HLA‑B27 positive, has joint hypermobility with frequent subluxations, sacroiliac joint osseous erosions, attention‑deficit/hyperactivity disorder‑type symptoms, reactive hypertension, subclinical postural orthostatic tachycardia syndrome (POTS), hydrotic eczema, psoriasiform epidermal hyperplasia and hyperkeratosis, and multiple chemical and food sensitivities?
Which labs should I order for hepatitis B serology, measles‑mumps‑rubella (MMR) IgG titers, and quantitative tuberculosis testing?
What are the anterior strap muscles of the neck, including their names, innervation, blood supply, and primary actions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.